Research map: Simultaneous Dual Type 2 Biologic Therapy Improves Sinonasal Outcomes in Selected Patients With Chronic Rhinosinusitis With Nasal Polyps

Back to the article

Papers in this map

  1. European Position Paper on Rhinosinusitis and Nasal Polyps 2020 · W.J. Fokkens · 2020 · 5961 citations · Cited by this paper
  2. Cashew Reaction Thresholds, Its Predictors, and Very Low Validated Safe Doses, in a Large Allergic Population (Nut CRACKER Study) · 2026 · Related
  3. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials · Philippe Gevaert · 2020 · 742 citations · Cited by this paper
  4. Detergent‐Containing Toothpaste Decreases Esophageal Mucosal Impedance and Alters Salivary Properties in Humans · 2026 · Related
  5. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease · Nan Zhang · 2008 · 627 citations · Cited by this paper
  6. Distinct Immunometabolic Profiles in Finnish and Russian Karelian Adolescents With Contrasting Allergy Risk · 2026 · Related
  7. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma · Michael E. Wechsler · 2021 · 427 citations · Cited by this paper
  8. Immunonutrition in Early Life: The Role of Complementary Feeding, Dietary Patterns, and Nutritional Exposures on the Health of Young Children—An EAACI Scoping Review · 2026 · Related
  9. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023 · W.J. Fokkens · 2023 · 294 citations · Cited by this paper
  10. Eosinophilia Reflects Type 2 Immune Activation in Newly Diagnosed Bullous Pemphigoid, With No Evidence of Charcot‐Leyden Crystals · 2026 · Related
  11. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper · Marek Jutel · 2023 · 291 citations · Cited by this paper
  12. Artemisia annua Sublingual Immunotherapy Is Efficacious and Well Tolerated in Patients With Season Allergic Rhinitis: A Prospective, Open‐Label, Multicenter Phase IV Trial · 2026 · Related
  13. Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps · Brian Jonathon Lipworth · 2025 · 204 citations · Cited by this paper
  14. The Airway Transcriptome in Type 2 Cytokine Biomarker‐High and ‐Low Severe Asthma · 2026 · Related
  15. Epidemiology and Differential Diagnosis of Nasal Polyps · Mohamad R. Chaaban · 2013 · 159 citations · Cited by this paper
  16. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps ( CRSwNP ): A multicentric observational Phase IV real‐life study ( DUPIREAL ) · Eugenio De Corso · 2023 · 159 citations · Cited by this paper
  17. A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps · Tim Delemarre · 2020 · 124 citations · Cited by this paper
  18. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial · Maria Greenwald · 2011 · 96 citations · Cited by this paper
  19. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis · Qingwu Wu · 2021 · 94 citations · Cited by this paper
  20. European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis · Philippe Gevaert · 2023 · 82 citations · Cited by this paper
  21. Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease · Michael Andrew Lawton · 2016 · 66 citations · Cited by this paper
  22. Thymic stromal lymphopoietin: a central regulator of allergic asthma · Brittany M. Watson · 2014 · 65 citations · Cited by this paper
  23. Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence · Shiru Cai · 2025 · 58 citations · Cited by this paper
  24. Safety of combining biologics in severe asthma: Asthma‐related and unrelated combinations · Marek Lommatzsch · 2022 · 46 citations · Cited by this paper
  25. Combination of Biological Therapy in Severe Asthma: Where We Are? · Lorenzo Carriera · 2023 · 36 citations · Cited by this paper
  26. Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making · Josje Janna Otten · 2023 · 34 citations · Cited by this paper
  27. Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases · Mitchell M. Pitlick · 2022 · 31 citations · Cited by this paper
  28. Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis · Victoria Furer · 2023 · 22 citations · Cited by this paper
  29. Switching biologics in chronic rhinosinusitis with nasal polyps: A multicenter Canadian experience · Marisa Dorling · 2024 · 21 citations · Cited by this paper
  30. Long-term efficacy and safety of different biologics in treatment of chronic rhinosinusitis with nasal polyps: A network meta-analysis · Han Chen · 2025 · 15 citations · Cited by this paper
  31. Long-term outcomes of combination biologic therapy in uncontrolled severe asthma: a case study · Andrea Baccelli · 2022 · 14 citations · Cited by this paper
  32. Combining Dual Biologics Therapy for Severe Asthma: A Series of Ten Cases · Yan Chen · 2025 · 14 citations · Cited by this paper
  33. The era of multiple biologics: Is combination and switching an option in the management of severe asthma? · Emmanuel Oshiogwe Okwuofu · 2025 · 12 citations · Cited by this paper
  34. Dual biologics for severe asthma and atopic dermatitis: Synopsis of two cases and literature review · Takeshi Matsumoto · 2023 · 11 citations · Cited by this paper
  35. Review of Dual Biologics in Specialty Pharmacy Practice · Lauren C. Quiroga · 2023 · 10 citations · Cited by this paper
  36. Combination Biologic Therapy with Mepolizumab and Dupilumab for Severe Eosinophilic Granulomatosis with Polyangiitis and Chronic Rhinosinusitis with Nasal Polyp · Yosuke Nakamura · 2024 · 9 citations · Cited by this paper
  37. Dual biologic therapy for the treatment of rheumatic diseases and asthma: a case series · Mariam Elmegaard Malik · 2022 · 9 citations · Cited by this paper
  38. Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma · İnsu Yılmaz · 2023 · 9 citations · Cited by this paper
  39. Treatment Approach to Chronic Rhinosinusitis Based on Endotype: Difference Between East and West · Junhai Chen · 2025 · 9 citations · Cited by this paper

Source: OpenAlex (CC0)